Literature DB >> 16310169

Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases.

Barbara Klajnert1, Marta Cortijo-Arellano, Maria Bryszewska, Josep Cladera.   

Abstract

Amyloid plaques composed of proteinaceous aggregates are commonly found in brains affected by Alzheimer's disease and spongiform encephalopaties. A structural homology has been recently described for the Alzheimer's peptide Abeta1-28 and the segment of the prion protein Prp185-208. In the present paper, further elements in common are reported: the aggregation processes are in both cases enhanced by the model glucosaminoglycan heparin and dendrimers can modulate the aggregation process by affecting the nucleation rate at low concentrations and the elongation rate at high concentrations. Nucleation and elongation rate constants are derived from fittings to a nucleation dependent polymerization model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16310169     DOI: 10.1016/j.bbrc.2005.11.053

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.

Authors:  Sibel Bozdağ Pehlivan
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

2.  Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification.

Authors:  Morikazu Imamura; Naoko Tabeta; Nobuko Kato; Yuichi Matsuura; Yoshifumi Iwamaru; Takashi Yokoyama; Yuichi Murayama
Journal:  J Biol Chem       Date:  2016-11-07       Impact factor: 5.157

3.  Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems.

Authors:  Sally Hunter; Carol Brayne
Journal:  Alzheimers Res Ther       Date:  2012-04-13       Impact factor: 6.982

4.  Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons.

Authors:  Raquel Ferrer-Lorente; Tania Lozano-Cruz; Irene Fernández-Carasa; Katarzyna Miłowska; Francisco Javier de la Mata; Maria Bryszewska; Antonella Consiglio; Paula Ortega; Rafael Gómez; Angel Raya
Journal:  Biomacromolecules       Date:  2021-10-06       Impact factor: 6.988

5.  Anti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc).

Authors:  James M McCarthy; Markus Franke; Ulrike K Resenberger; Sibeal Waldron; Jeremy C Simpson; Jörg Tatzelt; Dietmar Appelhans; Mark S Rogers
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

6.  Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity.

Authors:  Philipp Spitzer; Mateja Condic; Martin Herrmann; Timo Jan Oberstein; Marina Scharin-Mehlmann; Daniel F Gilbert; Oliver Friedrich; Teja Grömer; Johannes Kornhuber; Roland Lang; Juan Manuel Maler
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.